Latest Security News

Racura Oncology has secured governance approval to launch its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib in EGFR-mutated non-small cell lung cancer patients. This milestone sets the stage for a potentially pivotal new approach to overcoming resistance in lung cancer treatment.

Lynas Rare Earths has inked a binding Letter of Intent with the US Department of War to supply critical rare earth oxides over four years, backed by a US$96 million government allocation and a US$110/kg floor price for NdPr oxide.

Barton Gold Holdings has launched Phase 2 drilling at its Tunkillia Gold Project, aiming to upgrade resources and fast-track a mining lease application by year-end. The project’s strong economics and rising gold and silver prices underpin an optimistic development outlook.

ABx Group has announced a breakthrough with its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit, boasting higher heavy rare earth content and fewer impurities. This advancement enhances project flexibility and strengthens ABx’s position in the competitive rare earths market.

OD6 Metals has significantly expanded its claim holdings around the Quinn Fluorspar Project in Nevada, securing promising new exploration targets including the large Dresser epithermal alteration zone. This move strengthens its position in a critical mineral district vital to US supply chains.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.

Calix Limited has successfully completed the first milestone of its ARENA grant for the Zesty Green Iron Demonstration Project, unlocking a $2 million payment and marking a key step forward in its industrial decarbonisation efforts.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

Syrah Resources has secured an extension to the cure date for an alleged default under its Tesla offtake agreement, pushing the deadline from March to June 2026 as both parties work to resolve outstanding issues.

Neurizon Therapeutics announces the resignation of CEO Dr Michael Thurn, with Executive Chair Sergio Duchini stepping in temporarily as the company embarks on a global hunt for new leadership.

FAR Limited has agreed on a provisional US$23.7 million contingent payment from Woodside Energy tied to the Sangomar Project, prompting a proposed capital return of A$32.3 million to shareholders.

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.